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Resctive Oxygen Species Act as Mediators in 
Endothelial Cell Signall ing Pathways 
Kalkobad Iranl, Stavsn Sollolf, Loren Rnsolowski, Torah Rnkel, 
Maltrayee Sundaresan, Pascal J. Goldechmldt-Clarmont. The Johns 
Hopkins University, Baltimore MD, Gerontology Research Cent~, NIA 
Baltimore MD and Cardiology Branch, N.I.H., Bethesda MD 
Generation of reactive oxygen spacies(ROS) in response to conditions uch 
as Isohemla-reparfuslon has been associated with cellular damage. How- 
ever, recent evidence suggests that ROS may also be produced in response 
to cytoldnas and growth factors. We sought to investigate the role of ROS 
In endothelial cell signalling pathways. Addition of vascular ondothallal cell 
growth factor (VEGF 0.5 aM) to human agog endothelial cells (HAEC) re- 
sultad In a significant hough transient increase in ROS as assessed by 
the H202 sensitive tiuorophom dichloredihydrofluorescein dlacetate (DCF- 
DA). Furthermore, direct addition of H202 or H202 + sodium orthovanabato 
(NaOV) to HAEC produced a mad~ed and dose-dependent increase In pro- 
taln tymsine phosphorylation. Specific proteins involved in tymslno kinase 
signalling activated by 1-1202 and H20= + NaOV Included the VEGF receptor 
(fit-l) Itself, mitogen activated pmtaln kinase (MAPK) and phespholtpese C- 
gamma. In addition, concentrations of H202 (+/- NaOV) that lead to tyrosine 
phnspholylation also induced changes in the ac~n superstructure and mem- 
brane ruffling. This suggests that ROS such as H20,z act as intermediadas in 
endothelial signalling pathways and may mediate eessrr~al cellular functions 
such as migration and mitosis in response to growth fat/ors and changes in 
02 tension. 
~ Transcriptional Regulat ion of Inducible Nitric 
Oxide Synthase Expression in Cerd/ac M y ~  
Carmine v. Oddis, Mitchell S. Finkel. University of Pittsburgh, Pittsburgh, PA 
We have previously reported that Intedeukin-l# (IL-1) alone induced the 
transcription of nitric oxide synthase (iNOS) in isolated neonatal rat cardiac 
myocytas (CM). CM cultured with IL-1 for 48 hPS. stimulated nitrite (NO~) 
production, stained positively for iNOS protein and revealed mRNA for INOS 
by RT-PCR. Cytokines nave been shown to stimulate nuclear translocation of 
the transcription factor, NF-xB, in lymphocytes. The spedr¢ NF-¢B inhibitor, 
pyrmlldinedlthiocafoamate (PDTO), inhibited II.-1 indvced NO~ production 
by CM (6.7 4- 0.6 vs. 0.9 ± 0.3 nmof/1.25 x 10 s calls/48 hm.; p < 0.01; 
n = 12). Immunohlstochemioal staining revealed that PDTC Mocked II.-1 
stimulated NF-~B translocetion into the nucleus of CM. Tetrabydmbioptadn 
(BH4) is a co-factor for NOS activity. GTP cyclohydrolaso I is the rate-limiting 
enzyme in de nero BH4 synthesis. The GTP cyciohydrelese I inhibitor, 2, 
4.diamino-G-hydroxy.pydmldine (DAHP), also blocked IL-1 s~mulated NO~ 
formation by CM (6.7 4- 0.6 vs. 0.3.4- 0.1 nmol/1.25 x lO=celis/48 hrs.; 
p < 0,01; n = 12). RT-PCR revealed no INOS mRNA in ceils treated with 
IL-1 + PDTC. Cardiac myoojtes treated with |L-I + DAHP did e~ess  iNOS 
mRNA. Neither PDTC nor DAHP had any effect on GTP-cyclohydrolase I 
mRNA expression in cardiac myceytes. The membrane permeable analogue 
of Bl-b,, mathyI-BH4, (mBl.b,), only partially revered DAHP inhibition of NO~ 
formation. (6.7.4. 0.6 vs, 2.4 4- 0.3 nmol/1.25 x 10 s calls/48 hrs.; p < 0.01; 
n - 12). Thus, II.-1 stimulated INOS expression in CM requires nuclear 
translocetlon by NF-~B, but optimal NO~ production additionally requires 
GTP cyclohydreleso activity. 
~ 1y rosins Klnase Regulation of Phosphol l imse 
D-Protein C Klnase Pathway In laohemic 
Preconditioning 
NilanJana Mauflk, Masazuml Watanabe, Alpad Tosaki, Daniel Engelman, 
Yu-Feng, W. Ht~ang° Richard M. Engelman, John A. Rousou, David Deaton, 
Joseph Rack, Oipak K. Dos. University of Connect/cut School of Medicine, 
Farmington, CT 
Translocation and activation of protein C kinase (PKC) has been implicated in 
ischsmio preconditioning. Inan attempt o identify ths Intmcellular signaling 
pathway leading to PKC activation, we have examined the rote of protein 
tyroalne kinase (PTK) in isohemlc preconditioning. Isolated rat hearts were 
per[used for 10 rain with or without a PTK Inhibitor and then preconditioned by 
tour times repeated ischernla (5 rain), each followed by 10 rain of repedusion. 
Hea~s were sw~'.,hed to working mode and subjected to 30 rain ischemia 
followed by 30 mtn of reperfusion. Preconditioning led to the activation of PTK 
[45% vs. 20% for control] and phosphollpase D (PLD) [72 -*- 5.2 vs. 52 -~ 
4.6 for control] in concert with the increase in diacyiglycerol (DAG) formation 
[50 4- 2.1 vs. 32.4- 2.9 for control] and PKC activation [52"/0 vs. 25% for 
control]. Activation of TPK and increased second messenger production 
were associated with the enhanced tolerance of the hearts to ischemic 
reperfusion injury as evidenced by the signBcantly increased developed 
pressure (DP) [45,4 4- 1.4 vs. 35.4 ± 1.8 for control], dWdtm~ [2055 + 
89 vs. 1520 4- 63 for comml], arterial flow [24.3 ± 1.2 vs. 14.4 ± 0.7 
for coetrel] and ceronmy flow [19.6 4- 0.6 vs. 17.1 ± 0.4 for control] in the 
ischemic-reperfused hearts. Pretmatmant of the hearts with the TPK inhibitor 
completely abolished the precom~tioning phenomenon in conjunction with 
the inhibition of TPK and restoration of PLD, DAG and PKC at the central 
levels. The results of this stu~'y demonshata that PTK-PLD signaling plays 
a role in ischemio precond~oning and activation of PKC. 
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~ Abnormal HDI-3 and Ape Al-Mediated Cellular 
Cholesterol Etflux in Subjects With Familial HDL 
Deficiency 
Michel Marcil, Larbi Kdmbeu, Betsie Boucher, B.C. Solymoss, Jeffrey 
S. Cohn, Jacques Genest Jr.. Clinical Researoh Institute or Montreal and 
Montreal Heart Institute, Qudbec, Canada 
We have iden~md and characterized 4 probands with severn familial HDL 
deficiency (FHD) characterized by a lack of mature, a -mi~ng I.pAI HDL 
parliolas. Despite thorough dinicel, biochemical and molecular characteriza- 
tion, no known cause of HDL defmiency has been identified in these families. 
We examined the possibility that a cellular defect may cause an impaired 
HDL-mediated cholesterol efllux in FHD. RbmlNests were obtained from skin 
biopsies of normal and FHD subjects. Using cholesteroHoaded ceils, selec- 
tive radiolabeling of cellular cholesterol pools were used for effiux studies. 
Rrat, confluent growth-arrestad cells were labeled with pH]-cholasterel to 
spedlioally enrich plasma membrane as established by suc~.se density gra- 
dient ur~acentdfugetion; most of the PHl-cholesterel (80-95%) was found 
within the plasma membrane, In these conditions, normal HDI..~ (1 rng/mL of 
proteins) was able to desodb [sill.cholesterol from normal and FHD cells in 
a time dependent (up to 24 hours), linear kinetic fashion, with no d~erence 
in rates of efflux between FHD and normal cells. Second, to introduce a 
high fraction of label into intracellular compartments, cells were labeled with 
[3H}cholasterol during growth. Under these conddions, ape AI or HDL3 (100 
pg/mL of pmtalue) had a mad~edly reduced effect in promoting radiolabeled 
cholesterol e~lux in FHO cells (25-30%) compared with cells from normal 
subjects. When using pH]-mavalonol~one to label cells, signircandy tess 
newly synthesized etemls are found in the plasma membrane of FHD cells, 
compared with normal cells (==2-.-3-fold). This data show that intmcellular 
cholesterol elflux is abnormal in RID fibrabtasta nd suggest a defect in 
cellular tmlficking of cholesterol to the cell membrane. This would lead to the 
formation of small, lipid.dapleted nascent HDL parlJcles (prep mobility LpAi 
pmtides) that am rapidly cleared frem plasma. 
~ Abnomml Regulation of  the and CoA LDL-R HMG 
Reductese Genes in Subjects With Familial 
MHypercholesterolemia With the "French Canadian 
utat ion" 
Lu Yu, Shlqiang Qiu, Jacques Genoet Jr,. Clinical Raseamh Institute of 
MontrasJ; Montrda/Heart Ins//tuta, ~ ,  Qu~ Canada 
Familial hypechetasterelemla (R-I) is seen with high f~quency in Qu(ibec, 
Canada. A large deletion ( > 10 kb), 5' end of the low density lipopretein 
receptor (LDL-R) germ includes exon I and the promoter egion, and is the 
major mutation of the LDL-R in RI subjects in Quqribec (~'60% of cases). 
No mRNA is produced from the allele beadng the mutation. LDL-R protein 
expression is under the control of the non-detation allele. We studied the 
regulation of the LDL-R and HMG CoA red. genes in response to lovastatin 
(Lova) In cultured human skin tibrablasts. We determined mRNA levels of 
the LDL-R and HMG CoA red. genes by RNase protection assay in skin 
flbroblasts obtained from controls (n - 3) and subjects with RI (n = 6). 
We measured t=SI-LDL binding on skin tibroblasts grown in the presence of 
lipoprotalo defldant serum with, or without Leva. Control subjects oxhfoited 
coordinate regulation of the LDL-R and HMG CoA red. genes in response 
to Lova, 0.1-25 pM, for 0 to 24 bourn. Correlation coetficionts between 
